SS
PSTX

SBI Securities’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History

SBI Securities’s Portfolio PSTX Stock Details PSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,327
Closed -$12.7K – 4260
2024
Q4 		$12.7K Buy
+1,327
New +$6.92K ﹤0.01% 1543

Other funds holding PSTX

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

SBI Securities's PSTX Position: Q1 2025 in Review

SBI Securities sold out of Poseida Therapeutics, Inc. Common Stock (PSTX) in Q1 2025, closing a stake of 1,327 shares — an estimated $12.7K sold.

SBI Securities first reported a position in PSTX in Q4 2024 and held it in 1 quarter. The position peaked at $12.7K in Q4 2024. 1 fund tracked by Wall St. Rank holds PSTX as of Q1 2025.

  • SBI Securities reported no remaining Poseida Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • SBI Securities sold 1,327 Poseida Therapeutics, Inc. Common Stock shares in Q1 2025, an estimated $12.7K.
  • SBI Securities first reported a position in Poseida Therapeutics, Inc. Common Stock in Q4 2024 and held it in 1 quarter.
  • SBI Securities's Poseida Therapeutics, Inc. Common Stock position peaked at $12.7K in Q4 2024.
  • 1 fund tracked by Wall St. Rank held Poseida Therapeutics, Inc. Common Stock as of Q1 2025.

Based on SBI Securities's 13F filing for Q1 2025, filed 2 May 2025.